 | • レポートコード：QYR2104Z2955 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥565,500 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥848,250 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,131,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、ヒトマイクロバイオーム治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（FMT、マイクロバイオーム治療薬）、用途別市場規模（クロストリジウム・ディフィシル、クローン病、炎症性腸疾患、糖尿病、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・ヒトマイクロバイオーム治療の市場動向 ・企業の競争状況、市場シェア ・ヒトマイクロバイオーム治療の種類別市場規模（FMT、マイクロバイオーム治療薬） ・ヒトマイクロバイオーム治療の用途別市場規模（クロストリジウム・ディフィシル、クローン病、炎症性腸疾患、糖尿病、その他） ・ヒトマイクロバイオーム治療の北米市場規模2016-2027（アメリカ、カナダ） ・ヒトマイクロバイオーム治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・ヒトマイクロバイオーム治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ヒトマイクロバイオーム治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・ヒトマイクロバイオーム治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Enterome Bioscience、Rebiotix、Seres Therapeutics、Vedanta Biosciences、Bristol-Myers Squibb、Johnson & Johnson、Takeda Pharmaceutical） ・結論 |
Human microbiome has co-evolved with humans for centuries, which includes bacteria, viruses, fungi, Achaeans etc. The human microbiome is now one of the fastest growing areas of biology, and is considered as a newly discovered organ with the potential to have a tremendous impact on human health. Microbiome therapeutics are therapies that are designed to disrupt unhealthy microbial ecological networks and that catalyse the establishment of healthy ones.
One of the major drivers for this market is side effects of the existing treatments. Various medicines available in the market have several side-effects including minor headaches. These medicines may also impart serious side-effects such as liver or kidney injury, heart problems, and even death. The seriousness of side-effects drives the need for innovative treatment technologies, such as human microbiome therapeutics, that have reduced the negative impact on the human body. The demand for microbiome therapeutics is increasing since it provides treatment sans chemicals.
Market Analysis and Insights: Global Human Microbiome Therapeutics Market
The global Human Microbiome Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Human Microbiome Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Human Microbiome Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Human Microbiome Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Human Microbiome Therapeutics market.
Global Human Microbiome Therapeutics Scope and Market Size
Human Microbiome Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Human Microbiome Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
FMT
Microbiome Drugs
Segment by Application
C. difficile
Crohn’s Disease
Inflammatory Bowel Disease
Diabetes
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Enterome Bioscience
Rebiotix
Seres Therapeutics
Vedanta Biosciences
Bristol-Myers Squibb
Johnson & Johnson
Takeda Pharmaceutical
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Microbiome Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 FMT
1.2.3 Microbiome Drugs
1.3 Market by Application
1.3.1 Global Human Microbiome Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 C. difficile
1.3.3 Crohn’s Disease
1.3.4 Inflammatory Bowel Disease
1.3.5 Diabetes
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Human Microbiome Therapeutics Market Perspective (2016-2027)
2.2 Human Microbiome Therapeutics Growth Trends by Regions
2.2.1 Human Microbiome Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Human Microbiome Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Human Microbiome Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Human Microbiome Therapeutics Industry Dynamic
2.3.1 Human Microbiome Therapeutics Market Trends
2.3.2 Human Microbiome Therapeutics Market Drivers
2.3.3 Human Microbiome Therapeutics Market Challenges
2.3.4 Human Microbiome Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Human Microbiome Therapeutics Players by Revenue
3.1.1 Global Top Human Microbiome Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Human Microbiome Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Human Microbiome Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Human Microbiome Therapeutics Revenue
3.4 Global Human Microbiome Therapeutics Market Concentration Ratio
3.4.1 Global Human Microbiome Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Microbiome Therapeutics Revenue in 2020
3.5 Human Microbiome Therapeutics Key Players Head office and Area Served
3.6 Key Players Human Microbiome Therapeutics Product Solution and Service
3.7 Date of Enter into Human Microbiome Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Human Microbiome Therapeutics Breakdown Data by Type
4.1 Global Human Microbiome Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Human Microbiome Therapeutics Forecasted Market Size by Type (2022-2027)
5 Human Microbiome Therapeutics Breakdown Data by Application
5.1 Global Human Microbiome Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Human Microbiome Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Human Microbiome Therapeutics Market Size (2016-2027)
6.2 North America Human Microbiome Therapeutics Market Size by Type
6.2.1 North America Human Microbiome Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Human Microbiome Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Human Microbiome Therapeutics Market Size by Type (2016-2027)
6.3 North America Human Microbiome Therapeutics Market Size by Application
6.3.1 North America Human Microbiome Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Human Microbiome Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Human Microbiome Therapeutics Market Size by Application (2016-2027)
6.4 North America Human Microbiome Therapeutics Market Size by Country
6.4.1 North America Human Microbiome Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Human Microbiome Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Human Microbiome Therapeutics Market Size (2016-2027)
7.2 Europe Human Microbiome Therapeutics Market Size by Type
7.2.1 Europe Human Microbiome Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Human Microbiome Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Human Microbiome Therapeutics Market Size by Type (2016-2027)
7.3 Europe Human Microbiome Therapeutics Market Size by Application
7.3.1 Europe Human Microbiome Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Human Microbiome Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Human Microbiome Therapeutics Market Size by Application (2016-2027)
7.4 Europe Human Microbiome Therapeutics Market Size by Country
7.4.1 Europe Human Microbiome Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Human Microbiome Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Human Microbiome Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Human Microbiome Therapeutics Market Size by Type
8.2.1 Asia-Pacific Human Microbiome Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Human Microbiome Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Human Microbiome Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Human Microbiome Therapeutics Market Size by Application
8.3.1 Asia-Pacific Human Microbiome Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Human Microbiome Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Human Microbiome Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Human Microbiome Therapeutics Market Size by Region
8.4.1 Asia-Pacific Human Microbiome Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Human Microbiome Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Human Microbiome Therapeutics Market Size (2016-2027)
9.2 Latin America Human Microbiome Therapeutics Market Size by Type
9.2.1 Latin America Human Microbiome Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Human Microbiome Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Human Microbiome Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Human Microbiome Therapeutics Market Size by Application
9.3.1 Latin America Human Microbiome Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Human Microbiome Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Human Microbiome Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Human Microbiome Therapeutics Market Size by Country
9.4.1 Latin America Human Microbiome Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Human Microbiome Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Human Microbiome Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Human Microbiome Therapeutics Market Size by Type
10.2.1 Middle East & Africa Human Microbiome Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Human Microbiome Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Human Microbiome Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Human Microbiome Therapeutics Market Size by Application
10.3.1 Middle East & Africa Human Microbiome Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Human Microbiome Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Human Microbiome Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Human Microbiome Therapeutics Market Size by Country
10.4.1 Middle East & Africa Human Microbiome Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Human Microbiome Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Enterome Bioscience
11.1.1 Enterome Bioscience Company Details
11.1.2 Enterome Bioscience Business Overview
11.1.3 Enterome Bioscience Human Microbiome Therapeutics Introduction
11.1.4 Enterome Bioscience Revenue in Human Microbiome Therapeutics Business (2016-2021)
11.1.5 Enterome Bioscience Recent Development
11.2 Rebiotix
11.2.1 Rebiotix Company Details
11.2.2 Rebiotix Business Overview
11.2.3 Rebiotix Human Microbiome Therapeutics Introduction
11.2.4 Rebiotix Revenue in Human Microbiome Therapeutics Business (2016-2021)
11.2.5 Rebiotix Recent Development
11.3 Seres Therapeutics
11.3.1 Seres Therapeutics Company Details
11.3.2 Seres Therapeutics Business Overview
11.3.3 Seres Therapeutics Human Microbiome Therapeutics Introduction
11.3.4 Seres Therapeutics Revenue in Human Microbiome Therapeutics Business (2016-2021)
11.3.5 Seres Therapeutics Recent Development
11.4 Vedanta Biosciences
11.4.1 Vedanta Biosciences Company Details
11.4.2 Vedanta Biosciences Business Overview
11.4.3 Vedanta Biosciences Human Microbiome Therapeutics Introduction
11.4.4 Vedanta Biosciences Revenue in Human Microbiome Therapeutics Business (2016-2021)
11.4.5 Vedanta Biosciences Recent Development
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Details
11.5.2 Bristol-Myers Squibb Business Overview
11.5.3 Bristol-Myers Squibb Human Microbiome Therapeutics Introduction
11.5.4 Bristol-Myers Squibb Revenue in Human Microbiome Therapeutics Business (2016-2021)
11.5.5 Bristol-Myers Squibb Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Details
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Human Microbiome Therapeutics Introduction
11.6.4 Johnson & Johnson Revenue in Human Microbiome Therapeutics Business (2016-2021)
11.6.5 Johnson & Johnson Recent Development
11.7 Takeda Pharmaceutical
11.7.1 Takeda Pharmaceutical Company Details
11.7.2 Takeda Pharmaceutical Business Overview
11.7.3 Takeda Pharmaceutical Human Microbiome Therapeutics Introduction
11.7.4 Takeda Pharmaceutical Revenue in Human Microbiome Therapeutics Business (2016-2021)
11.7.5 Takeda Pharmaceutical Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Human Microbiome Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of FMT
Table 3. Key Players of Microbiome Drugs
Table 4. Global Human Microbiome Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Human Microbiome Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Human Microbiome Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Human Microbiome Therapeutics Market Share by Regions (2016-2021)
Table 8. Global Human Microbiome Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Human Microbiome Therapeutics Market Share by Regions (2022-2027)
Table 10. Human Microbiome Therapeutics Market Trends
Table 11. Human Microbiome Therapeutics Market Drivers
Table 12. Human Microbiome Therapeutics Market Challenges
Table 13. Human Microbiome Therapeutics Market Restraints
Table 14. Global Human Microbiome Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Human Microbiome Therapeutics Market Share by Players (2016-2021)
Table 16. Global Top Human Microbiome Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Microbiome Therapeutics as of 2020)
Table 17. Ranking of Global Top Human Microbiome Therapeutics Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Human Microbiome Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Human Microbiome Therapeutics Product Solution and Service
Table 21. Date of Enter into Human Microbiome Therapeutics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Human Microbiome Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Human Microbiome Therapeutics Revenue Market Share by Type (2016-2021)
Table 25. Global Human Microbiome Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Human Microbiome Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Human Microbiome Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Human Microbiome Therapeutics Revenue Market Share by Application (2016-2021)
Table 29. Global Human Microbiome Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Human Microbiome Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Human Microbiome Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Human Microbiome Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Human Microbiome Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Human Microbiome Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Human Microbiome Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Human Microbiome Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Human Microbiome Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Human Microbiome Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Human Microbiome Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Human Microbiome Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Human Microbiome Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Human Microbiome Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Human Microbiome Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Human Microbiome Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Human Microbiome Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Human Microbiome Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Human Microbiome Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Human Microbiome Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Human Microbiome Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Human Microbiome Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Human Microbiome Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Human Microbiome Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Human Microbiome Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Human Microbiome Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Human Microbiome Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Human Microbiome Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Human Microbiome Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Human Microbiome Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Human Microbiome Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Human Microbiome Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 61. Enterome Bioscience Company Details
Table 62. Enterome Bioscience Business Overview
Table 63. Enterome Bioscience Human Microbiome Therapeutics Product
Table 64. Enterome Bioscience Revenue in Human Microbiome Therapeutics Business (2016-2021) & (US$ Million)
Table 65. Enterome Bioscience Recent Development
Table 66. Rebiotix Company Details
Table 67. Rebiotix Business Overview
Table 68. Rebiotix Human Microbiome Therapeutics Product
Table 69. Rebiotix Revenue in Human Microbiome Therapeutics Business (2016-2021) & (US$ Million)
Table 70. Rebiotix Recent Development
Table 71. Seres Therapeutics Company Details
Table 72. Seres Therapeutics Business Overview
Table 73. Seres Therapeutics Human Microbiome Therapeutics Product
Table 74. Seres Therapeutics Revenue in Human Microbiome Therapeutics Business (2016-2021) & (US$ Million)
Table 75. Seres Therapeutics Recent Development
Table 76. Vedanta Biosciences Company Details
Table 77. Vedanta Biosciences Business Overview
Table 78. Vedanta Biosciences Human Microbiome Therapeutics Product
Table 79. Vedanta Biosciences Revenue in Human Microbiome Therapeutics Business (2016-2021) & (US$ Million)
Table 80. Vedanta Biosciences Recent Development
Table 81. Bristol-Myers Squibb Company Details
Table 82. Bristol-Myers Squibb Business Overview
Table 83. Bristol-Myers Squibb Human Microbiome Therapeutics Product
Table 84. Bristol-Myers Squibb Revenue in Human Microbiome Therapeutics Business (2016-2021) & (US$ Million)
Table 85. Bristol-Myers Squibb Recent Development
Table 86. Johnson & Johnson Company Details
Table 87. Johnson & Johnson Business Overview
Table 88. Johnson & Johnson Human Microbiome Therapeutics Product
Table 89. Johnson & Johnson Revenue in Human Microbiome Therapeutics Business (2016-2021) & (US$ Million)
Table 90. Johnson & Johnson Recent Development
Table 91. Takeda Pharmaceutical Company Details
Table 92. Takeda Pharmaceutical Business Overview
Table 93. Takeda Pharmaceutical Human Microbiome Therapeutics Product
Table 94. Takeda Pharmaceutical Revenue in Human Microbiome Therapeutics Business (2016-2021) & (US$ Million)
Table 95. Takeda Pharmaceutical Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Human Microbiome Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. FMT Features
Figure 3. Microbiome Drugs Features
Figure 4. Global Human Microbiome Therapeutics Market Share by Application: 2020 VS 2027
Figure 5. C. difficile Case Studies
Figure 6. Crohn’s Disease Case Studies
Figure 7. Inflammatory Bowel Disease Case Studies
Figure 8. Diabetes Case Studies
Figure 9. Others Case Studies
Figure 10. Human Microbiome Therapeutics Report Years Considered
Figure 11. Global Human Microbiome Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Human Microbiome Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Human Microbiome Therapeutics Market Share by Regions: 2020 VS 2027
Figure 14. Global Human Microbiome Therapeutics Market Share by Regions (2022-2027)
Figure 15. Global Human Microbiome Therapeutics Market Share by Players in 2020
Figure 16. Global Top Human Microbiome Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Microbiome Therapeutics as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Human Microbiome Therapeutics Revenue in 2020
Figure 18. Global Human Microbiome Therapeutics Revenue Market Share by Type (2016-2021)
Figure 19. Global Human Microbiome Therapeutics Revenue Market Share by Type (2022-2027)
Figure 20. North America Human Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Human Microbiome Therapeutics Market Share by Type (2016-2027)
Figure 22. North America Human Microbiome Therapeutics Market Share by Application (2016-2027)
Figure 23. North America Human Microbiome Therapeutics Market Share by Country (2016-2027)
Figure 24. United States Human Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Human Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Human Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Human Microbiome Therapeutics Market Share by Type (2016-2027)
Figure 28. Europe Human Microbiome Therapeutics Market Share by Application (2016-2027)
Figure 29. Europe Human Microbiome Therapeutics Market Share by Country (2016-2027)
Figure 30. Germany Human Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Human Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Human Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Human Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Human Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Human Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Human Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Human Microbiome Therapeutics Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Human Microbiome Therapeutics Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Human Microbiome Therapeutics Market Share by Region (2016-2027)
Figure 40. China Human Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Human Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Human Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Human Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Human Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Human Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Human Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Human Microbiome Therapeutics Market Share by Type (2016-2027)
Figure 48. Latin America Human Microbiome Therapeutics Market Share by Application (2016-2027)
Figure 49. Latin America Human Microbiome Therapeutics Market Share by Country (2016-2027)
Figure 50. Mexico Human Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Human Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Human Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Human Microbiome Therapeutics Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Human Microbiome Therapeutics Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Human Microbiome Therapeutics Market Share by Country (2016-2027)
Figure 56. Turkey Human Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Human Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Human Microbiome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Enterome Bioscience Revenue Growth Rate in Human Microbiome Therapeutics Business (2016-2021)
Figure 60. Rebiotix Revenue Growth Rate in Human Microbiome Therapeutics Business (2016-2021)
Figure 61. Seres Therapeutics Revenue Growth Rate in Human Microbiome Therapeutics Business (2016-2021)
Figure 62. Vedanta Biosciences Revenue Growth Rate in Human Microbiome Therapeutics Business (2016-2021)
Figure 63. Bristol-Myers Squibb Revenue Growth Rate in Human Microbiome Therapeutics Business (2016-2021)
Figure 64. Johnson & Johnson Revenue Growth Rate in Human Microbiome Therapeutics Business (2016-2021)
Figure 65. Takeda Pharmaceutical Revenue Growth Rate in Human Microbiome Therapeutics Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
世界のヒトマイクロバイオーム治療薬・診断市場規模・現状・予測（2021年-2027年） The modern approach involves exploiting the interaction between humans and the bacteria that live in or on the body to develop new drugs and therapies to treat chronic diseases such as diabetes. These microbiomes derived drugs help the physician in better diagnosis of the illness. Rising cases of ch…- 世界のヒトマイクロバイオーム市場規模・現状・予測（2021年-2027年） The Human Microbiome is the collection of all the microorganisms living in association with the human body. These communities consist of a variety of microorganisms including eukaryotes, archaea, bacteria and viruses. Bacteria in an average human body number ten times more than human cells, for a to…
- 世界のヒトマイクロバイオームシーケンシング市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Human Microbiome Sequencing Market The global Human Microbiome Sequencing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity…
- 世界のマイクロバイオーム医薬品市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Microbiome Drugs Market The global Microbiome Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes a b…
- 世界のヒトマイクロバイオームシーケンシング技術市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Human Microbiome Sequencing Technology Market The global Human Microbiome Sequencing Technology market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis a…